Immunohistochemical, in situ hybridization, and ultrastructural localization of SARS-associated coronavirus in lung of a fatal case of severe acute respiratory syndrome in Taiwan.

PubWeight™: 1.21‹?› | Rank: Top 10%

🔗 View Article (PMID 15791576)

Published in Hum Pathol on March 01, 2005

Authors

Wun-Ju Shieh1, Cheng-Hsiang Hsiao, Christopher D Paddock, Jeannette Guarner, Cynthia S Goldsmith, Kathleen Tatti, Michelle Packard, Laurie Mueller, Mu-Zong Wu, Pierre Rollin, Ih-Jen Su, Sherif R Zaki

Author Affiliations

1: Infectious Disease Pathology Activity, Division of Viral and Rickettsial Diseases, Center for Disease Control and Prevention, Atlanta, GA 30333, USA.

Articles citing this

2009 pandemic influenza A (H1N1): pathology and pathogenesis of 100 fatal cases in the United States. Am J Pathol (2010) 3.32

A mouse-adapted SARS-coronavirus causes disease and mortality in BALB/c mice. PLoS Pathog (2007) 2.71

Aged BALB/c mice as a model for increased severity of severe acute respiratory syndrome in elderly humans. J Virol (2005) 1.79

Severe acute respiratory syndrome coronavirus infection of golden Syrian hamsters. J Virol (2005) 1.75

Severe acute respiratory syndrome coronavirus infection of mice transgenic for the human Angiotensin-converting enzyme 2 virus receptor. J Virol (2006) 1.49

Time course and cellular localization of SARS-CoV nucleoprotein and RNA in lungs from fatal cases of SARS. PLoS Med (2006) 1.31

SARS-CoV replicates in primary human alveolar type II cell cultures but not in type I-like cells. Virology (2007) 1.09

Pathology and pathogenesis of severe acute respiratory syndrome. Am J Pathol (2007) 1.09

Modeling the early events of severe acute respiratory syndrome coronavirus infection in vitro. J Virol (2006) 1.04

Molecular pathology in the lungs of severe acute respiratory syndrome patients. Am J Pathol (2007) 0.96

A novel subset of putative stem/progenitor CD34+Oct-4+ cells is the major target for SARS coronavirus in human lung. J Exp Med (2007) 0.91

Innate immune response of human alveolar type II cells infected with severe acute respiratory syndrome-coronavirus. Am J Respir Cell Mol Biol (2013) 0.88

Human coronavirus HKU1 infection of primary human type II alveolar epithelial cells: cytopathic effects and innate immune response. PLoS One (2013) 0.88

Neutralizing human monoclonal antibodies to severe acute respiratory syndrome coronavirus: target, mechanism of action, and therapeutic potential. Rev Med Virol (2011) 0.83

The open reading frame 3a protein of severe acute respiratory syndrome-associated coronavirus promotes membrane rearrangement and cell death. J Virol (2009) 0.83

Rat respiratory coronavirus infection: replication in airway and alveolar epithelial cells and the innate immune response. J Gen Virol (2009) 0.81

Host-pathogen interactions during coronavirus infection of primary alveolar epithelial cells. J Leukoc Biol (2009) 0.81

Differentiated phenotypes of primary murine alveolar epithelial cells and their susceptibility to infection by respiratory viruses. Virus Res (2013) 0.77

Articles by these authors

A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med (2003) 29.55

Probable person-to-person transmission of avian influenza A (H5N1). N Engl J Med (2005) 14.59

Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. N Engl J Med (2010) 9.90

Avian influenza (H5N1) viruses isolated from humans in Asia in 2004 exhibit increased virulence in mammals. J Virol (2005) 7.88

A new arenavirus in a cluster of fatal transplant-associated diseases. N Engl J Med (2008) 7.73

Tick-borne rickettsioses around the world: emerging diseases challenging old concepts. Clin Microbiol Rev (2005) 7.02

Influenza-associated deaths among children in the United States, 2003-2004. N Engl J Med (2005) 6.83

Multiple Ebola virus transmission events and rapid decline of central African wildlife. Science (2004) 5.49

Transmission of lymphocytic choriomeningitis virus by organ transplantation. N Engl J Med (2006) 5.42

Investigation of bioterrorism-related anthrax, United States, 2001: epidemiologic findings. Emerg Infect Dis (2002) 5.23

Rickettsia parkeri: a newly recognized cause of spotted fever rickettsiosis in the United States. Clin Infect Dis (2004) 4.83

Fatal toxic shock syndrome associated with Clostridium sordellii after medical abortion. N Engl J Med (2005) 4.69

Isolation of genetically diverse Marburg viruses from Egyptian fruit bats. PLoS Pathog (2009) 4.56

A new phlebovirus associated with severe febrile illness in Missouri. N Engl J Med (2012) 4.15

Transmission of rabies virus from an organ donor to four transplant recipients. N Engl J Med (2005) 4.05

Marburgvirus genomics and association with a large hemorrhagic fever outbreak in Angola. J Virol (2006) 4.01

Role of host cytokine responses in the pathogenesis of avian H5N1 influenza viruses in mice. J Virol (2006) 4.00

Prior infection and passive transfer of neutralizing antibody prevent replication of severe acute respiratory syndrome coronavirus in the respiratory tract of mice. J Virol (2004) 3.76

Discovery of swine as a host for the Reston ebolavirus. Science (2009) 3.68

Rocky Mountain spotted fever from an unexpected tick vector in Arizona. N Engl J Med (2005) 3.58

Person-to-person transmission of Nipah virus in a Bangladeshi community. Emerg Infect Dis (2007) 3.47

Diagnosis and management of tickborne rickettsial diseases: Rocky Mountain spotted fever, ehrlichioses, and anaplasmosis--United States: a practical guide for physicians and other health-care and public health professionals. MMWR Recomm Rep (2006) 3.32

2009 pandemic influenza A (H1N1): pathology and pathogenesis of 100 fatal cases in the United States. Am J Pathol (2010) 3.32

Fatal inhalational anthrax in a 94-year-old Connecticut woman. JAMA (2002) 3.26

Bat Nipah virus, Thailand. Emerg Infect Dis (2005) 3.22

Virology, pathology, and clinical manifestations of West Nile virus disease. Emerg Infect Dis (2005) 3.15

Update on tick-borne rickettsioses around the world: a geographic approach. Clin Microbiol Rev (2013) 2.97

Milrinone therapy for enterovirus 71-induced pulmonary edema and/or neurogenic shock in children: a randomized controlled trial. Crit Care Med (2013) 2.88

Waning immunity to plasma-derived hepatitis B vaccine and the need for boosters 15 years after neonatal vaccination. Hepatology (2004) 2.74

A mouse-adapted SARS-coronavirus causes disease and mortality in BALB/c mice. PLoS Pathog (2007) 2.71

The ascendancy of Amblyomma americanum as a vector of pathogens affecting humans in the United States. Annu Rev Entomol (2002) 2.70

Astrovirus encephalitis in boy with X-linked agammaglobulinemia. Emerg Infect Dis (2010) 2.69

Epidemiologic and laboratory features of a large outbreak of pertussis-like illnesses associated with cocirculating Bordetella holmesii and Bordetella pertussis--Ohio, 2010-2011. Clin Infect Dis (2012) 2.64

Change of major genotype of enterovirus 71 in outbreaks of hand-foot-and-mouth disease in Taiwan between 1998 and 2000. J Clin Microbiol (2002) 2.64

Genome sequencing and comparative analysis of Klebsiella pneumoniae NTUH-K2044, a strain causing liver abscess and meningitis. J Bacteriol (2009) 2.64

A revisit of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in non-Hodgkin's lymphoma: a randomized trial. Hepatology (2008) 2.55

Myocardial injury and bacterial pneumonia contribute to the pathogenesis of fatal influenza B virus infection. J Infect Dis (2012) 2.48

Monkeypox transmission and pathogenesis in prairie dogs. Emerg Infect Dis (2004) 2.45

A large outbreak of typhoid fever associated with a high rate of intestinal perforation in Kasese District, Uganda, 2008-2009. Clin Infect Dis (2012) 2.40

Reemergence of enterovirus 71 in 2008 in taiwan: dynamics of genetic and antigenic evolution from 1998 to 2008. J Clin Microbiol (2009) 2.40

Nipah virus infection: pathology and pathogenesis of an emerging paramyxoviral zoonosis. Am J Pathol (2002) 2.36

Pathogenesis of enterovirus 71 brainstem encephalitis in pediatric patients: roles of cytokines and cellular immune activation in patients with pulmonary edema. J Infect Dis (2003) 2.36

Rickettsia parkeri rickettsiosis and its clinical distinction from Rocky Mountain spotted fever. Clin Infect Dis (2008) 2.27

A human colorectal explant culture to evaluate topical microbicides for the prevention of HIV infection. J Infect Dis (2005) 2.26

Generation of eGFP expressing recombinant Zaire ebolavirus for analysis of early pathogenesis events and high-throughput antiviral drug screening. Virology (2005) 2.25

Preclinical testing of candidate topical microbicides for anti-human immunodeficiency virus type 1 activity and tissue toxicity in a human cervical explant culture. Antimicrob Agents Chemother (2007) 2.22

Malignant Transformation of Hymenolepis nana in a Human Host. N Engl J Med (2015) 2.21

Steroid-free chemotherapy decreases risk of hepatitis B virus (HBV) reactivation in HBV-carriers with lymphoma. Hepatology (2003) 2.15

Pathology and pathogenesis of bioterrorism-related inhalational anthrax. Am J Pathol (2003) 2.11

A mouse-adapted enterovirus 71 strain causes neurological disease in mice after oral infection. J Virol (2004) 2.10

Successful topical respiratory tract immunization of primates against Ebola virus. J Virol (2007) 2.06

Diagnosis and management of Q fever--United States, 2013: recommendations from CDC and the Q Fever Working Group. MMWR Recomm Rep (2013) 2.06

Epidemiologic and clinical aspects of a Rift Valley fever outbreak in humans in Tanzania, 2007. Am J Trop Med Hyg (2010) 2.03

Subacute sclerosing panencephalitis: more cases of this fatal disease are prevented by measles immunization than was previously recognized. J Infect Dis (2005) 2.01

Rickettsia 364D: a newly recognized cause of eschar-associated illness in California. Clin Infect Dis (2010) 2.00

Seasonal pulses of Marburg virus circulation in juvenile Rousettus aegyptiacus bats coincide with periods of increased risk of human infection. PLoS Pathog (2012) 2.00

Inhibition of IRF-3 activation by VP35 is critical for the high level of virulence of ebola virus. J Virol (2008) 1.96

Risk factors for Buruli ulcer disease (Mycobacterium ulcerans Infection): results from a case-control study in Ghana. Clin Infect Dis (2005) 1.95

SARS in healthcare facilities, Toronto and Taiwan. Emerg Infect Dis (2004) 1.95

Evidence-based guidelines from ESPGHAN and NASPGHAN for Helicobacter pylori infection in children. J Pediatr Gastroenterol Nutr (2011) 1.95

Tissue and cellular tropism, pathology and pathogenesis of Ebola and Marburg viruses. J Pathol (2015) 1.91

Endoplasmic reticulum stress stimulates the expression of cyclooxygenase-2 through activation of NF-kappaB and pp38 mitogen-activated protein kinase. J Biol Chem (2004) 1.86

An interferon-gamma-related cytokine storm in SARS patients. J Med Virol (2005) 1.83

Establishing a nationwide emergency department-based syndromic surveillance system for better public health responses in Taiwan. BMC Public Health (2008) 1.81

Reemerging leptospirosis, California. Emerg Infect Dis (2004) 1.81

Acute muscular sarcocystosis: an international investigation among ill travelers returning from Tioman Island, Malaysia, 2011-2012. Clin Infect Dis (2014) 1.80

Persistent neuroinvasive West Nile virus infection in an immunocompromised patient. Clin Infect Dis (2006) 1.76

Complete nucleotide sequence of pK245, a 98-kilobase plasmid conferring quinolone resistance and extended-spectrum-beta-lactamase activity in a clinical Klebsiella pneumoniae isolate. Antimicrob Agents Chemother (2006) 1.76

Ultrastructural characterization of SARS coronavirus. Emerg Infect Dis (2004) 1.76

Severe acute respiratory syndrome coronavirus infection of golden Syrian hamsters. J Virol (2005) 1.75

Passive surveillance as an instrument to identify risk factors for fatal Rocky Mountain spotted fever: is there more to learn? Am J Trop Med Hyg (2002) 1.73